Microbiome changes in humans with Parkinson’s disease after photobiomodulation therapy: a retrospective study

Brian Bicknell*, Ann Liebert, Craig S. McLachlan, Hosen Kiat

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
38 Downloads (Pure)

Abstract

There is a paucity of information on the effect of photobiomodulation therapy on gut micro-biome composition. Parkinson’s disease is a progressive neurological disorder with few management options, although the gut microbiome has been suggested as a potential avenue of treatment. We retrospectively analysed the microbiome from human stool samples from a previously published study, which had demonstrated the efficacy of photobiomodulation to treat Parkinson’s patients’ symptoms. Specifically, we have observed changes in the microbiome of Parkinson’s patients after a 12-week treatment regimen with photobiomodulation to the abdomen, neck, head and nose. Noted were positive changes in the Firmicutes to Bacteroidetes (F:B) ratio, which is often interpreted as a proxy for gut health.

Original languageEnglish
Article number49
Pages (from-to)1-15
Number of pages15
JournalJournal of Personalized Medicine
Volume12
Issue number1
DOIs
Publication statusPublished - 5 Jan 2022

Bibliographical note

Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Microbiome
  • Parkinson’s disease
  • Photobiomodulation

Fingerprint

Dive into the research topics of 'Microbiome changes in humans with Parkinson’s disease after photobiomodulation therapy: a retrospective study'. Together they form a unique fingerprint.

Cite this